To Know the Role of Gambhari(Kashmari) and Yashtimadhu in Asrigdara(Dysfunctional Uterine Bleeding).

Phase 2/3

Not yet recruiting

• Conditions: Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: Asrigdara (Dysfunctional Uterine Bleeding ), (2) ICD-10 Condition: N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: Asrigdara (Dysfunctional Uterine Bleeding ),

• Registration Number: CTRI/2022/10/046166
• Lead Sponsor: Rishikul Campus Uttarakhand Ayurved University

Brief Summary

Among the gynecological disorders Asrigdara is one of the most common menstrual bleeding associated with excessive menstrual bleeding with or without intermenstrual bleeding. It is a considerable health care burden for a women and has adefinite effect on her quality of life.In classical texts many preparation have been described for treatment and managment of Asrigdara, among from them ,the present study is a small effort to compare the efficiency of Kasmari(Gambhari ) phala churna and Yashtimadhu moola churna. in Ayurveda these to drugs are explained as hemostatic drugs in many bleeding disorders.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-11
• Last Update Posted: 2022-03-10

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

1.Classical Symptoms of Asrigdara(Aartava Atipravariti,Angmarda,Vedana) 2.Continuous Vaginal Bleeding 3.History of Heavy Vaginal Bleeding 4.Increased Vaginal Bleeding with Irregularities in the Frequency of Menstrual Cycle.

Exclusion Criteria

• 1. Severe Anemia Patients 2. Systemic Disease.
• Bleeding Disorder,Uncontrolled Diabetes Mellitus,Hypertension,Heart Disease,Thyroid Dysfunction. 3. Pelvic Disease.
• Fibroid ,Benign/Malignant Tumors of Ovary, Sexual Transmitted Disease 4.Others Serious Medical & Surgical ill Patients 5.Patients with Intra Uterine Devices.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.Relief in heavy menstrual bleeding.	Observation of the patient during treatment for 3 consecutive menstrual cycles and follow up for another 2 consecutive menstrual cycles after completion of the treatment.Total duration is 5 month.
2.Relief in Irregularities in the	Observation of the patient during treatment for 3 consecutive menstrual cycles and follow up for another 2 consecutive menstrual cycles after completion of the treatment.Total duration is 5 month.
Frequency of Menstrual Cycle.	Observation of the patient during treatment for 3 consecutive menstrual cycles and follow up for another 2 consecutive menstrual cycles after completion of the treatment.Total duration is 5 month.
3.Relief in pain during mensuration.	Observation of the patient during treatment for 3 consecutive menstrual cycles and follow up for another 2 consecutive menstrual cycles after completion of the treatment.Total duration is 5 month.

Secondary Outcome Measures

Name	Time	Method
Improvement in menstrual health and reproductive health of women.	1 year

Trial Locations

Locations (1)

Gurukul Campus; 🇮🇳 Hardwar, UTTARANCHAL, India

Gurukul Campus

🇮🇳Hardwar, UTTARANCHAL, India

Radhika Kumiya

Principal investigator

8739923979

drradhikakumiya@gmail.com